Export

ATC codes: J01CA04
EMLc
Indication
Acute pharyngitis ICD11 code: CA02
INN
Amoxicillin
Medicine type
Chemical agent
Antibiotic groups
List type
Core (EML)
(EMLc)
Formulations
Oral > Liquid: 125 mg per 5 mL (as trihydrate) powder for oral liquid (EMLc) ; 250 mg per 5 mL (as trihydrate) powder for oral liquid (EMLc)
Parenteral > General injections > unspecified: 250 mg in vial (as sodium) powder for injection ; 500 mg in vial (as sodium) powder for injection ; 1 g in vial (as sodium) powder for injection
Oral > Solid > dispersible tablet: 250 mg (scored) (as trihydrate) (EMLc) ; 500 mg (scored) (as trihydrate) (EMLc)
Oral > Solid > dosage form: 250 mg (as trihydrate) ; 500 mg (as trihydrate)
EML status history
First added in 2017 (TRS 1006)
Changed in 2023 (TRS 1049)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Wikipedia
DrugBank
Expert Committee recommendation
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended: - the addition of new formulations of amoxicillin (dispersible, scored tablet, 250 mg and 500 mg) to the EMLc. - the addition of new formulations of cefalexin (dispersible tablet 125 mg and 250 mg) to the EMLc. - the addition of a new strength formulation of clarithromycin (solid oral dosage form 250 mg) to the EMLc. - the deletion of clarithromycin 500 mg solid oral dosage form from the EMLc.
EML recommendations: Acute pharyngitis
First choice
Second choice
Watchful waiting, symptom relief and no antibiotic treatment should be considered as the first-line treatment option.
First choice
Second choice